Adolescents and young adults in the U.S. are increasingly using popular GLP-1 weight-loss drugs alone or in conjunction with metabolic and bariatric surgery (MBS) to manage obesity, according to a study by UT Southwestern Medical […]
Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage. University of Mississippi researchers are examining why and where that leaves patients.This article was originally published […]
New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (15–17 July), shows that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss […]
From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval are often more nuanced than the […]
Individuals with overweight or obesity can have a higher risk of heart disease despite appearing to be healthy, new research presented at the International Congress on Obesity in Mexico City (15–17 July) shows. Using waist-based […]
New research has found that eating habits that align most closely with a woman’s existing routine show promise for losing postpartum baby weight, especially for mothers earlier in the postpartum period. The study identified key […]
A study of more than 1 million women has found that excessive weight gain during pregnancy is linked to an increased risk of potentially life-threatening complications, regardless of whether starting weights were considered underweight, normal, […]
New research presented at this year’s International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (July 15–17), reveals that few of the world’s 21 largest food retailers are […]
The effect of obesity on unemployment is more than twice as large as previously thought, finds a UK Biobank study of genetic evidence.This article was originally published on MedicalXpress.com
Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong—and some patients may unknowingly be receiving products from pharmacies with concerning regulatory histories, according to new research […]
© 2025 SimplyWell.ca